Health & Life Co., Ltd. (TPEX:1781)
Taiwan · Delayed Price · Currency is TWD 10.75
-0.10 (-0.92%)
Aug 26, 2026, 1:30 PM CST
Health & Life Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 514 | 524 | 851 | 804 | 723 | 742 | |
Market Cap Growth | -20.51% | -38.44% | 5.90% | 11.15% | -2.56% | -39.81% |
Enterprise Value | 490 | 497 | 830 | 765 | 713 | 624 |
Last Close Price | 10.85 | 11.05 | 17.95 | 16.95 | 15.25 | 15.65 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 35.11 | - | - | - |
PS Ratio | 1.29 | 1.32 | 1.21 | 1.34 | 0.91 | 0.91 |
PB Ratio | 1.70 | 1.63 | 2.17 | 2.40 | 1.94 | 1.96 |
P/TBV Ratio | 1.70 | 1.64 | 2.18 | 2.43 | 1.98 | 1.97 |
P/FCF Ratio | - | - | 27.76 | 10.44 | - | - |
P/OCF Ratio | - | 164.53 | 25.48 | 9.46 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.22 | 1.25 | 1.18 | 1.27 | 0.89 | 0.77 |
EV/EBITDA Ratio | - | - | 57.22 | - | - | - |
EV/EBIT Ratio | - | - | 332.62 | - | - | - |
EV/FCF Ratio | - | - | 27.07 | 9.94 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.65 | 0.61 | 0.54 | 0.34 | 0.51 | 0.36 |
Debt / EBITDA Ratio | - | - | 8.24 | - | - | - |
Debt / FCF Ratio | - | - | 6.98 | 1.48 | - | - |
Net Debt / Equity Ratio | -0.08 | -0.16 | -0.16 | -0.11 | 0.09 | -0.17 |
Net Debt / EBITDA Ratio | 0.38 | 0.96 | -4.34 | 1.27 | -0.95 | 0.73 |
Net Debt / FCF Ratio | 1.00 | 13.58 | -2.06 | -0.48 | -0.38 | 0.46 |
Asset Turnover | 0.60 | 0.52 | 0.93 | 0.80 | 1.01 | 0.91 |
Inventory Turnover | 3.16 | 2.63 | 3.28 | 2.26 | 2.93 | 3.51 |
Quick Ratio | 1.86 | 1.66 | 1.88 | 0.74 | 0.80 | 0.88 |
Current Ratio | 2.71 | 2.39 | 2.62 | 1.43 | 1.53 | 1.66 |
Return on Equity (ROE) | -15.59% | -17.28% | 6.65% | -9.39% | -4.67% | -15.22% |
Return on Assets (ROA) | -7.02% | -5.15% | 0.20% | -3.40% | -3.52% | -6.78% |
Return on Invested Capital (ROIC) | -27.32% | -21.14% | 0.67% | -11.68% | -12.36% | -36.29% |
Return on Capital Employed (ROCE) | -15.00% | -12.30% | 0.40% | -11.40% | -10.40% | -22.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -9.85% | -11.77% | 2.85% | -4.13% | -2.43% | -8.40% |
FCF Yield | -4.74% | -0.71% | 3.60% | 9.57% | -11.82% | -19.35% |
Buyback Yield / Dilution | 0.21% | 5.96% | -6.34% | - | - | 0.21% |